KEY FEATURES
Full Name | Cluster Of Differentiation 34 |
---|---|
Synonym | Hematopoietic progenitor cell antigen CD34 |
Assay Type | Sandwich |
Reactivity | Human |
Range | 0.31-20ng/mL |
Sensitivity | 0.12ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CD34 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CD34. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CD34 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CD34, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CD34. You can calculate the concentration of Human CD34 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CD34 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 1.08 | 2.6 | 7.95 | 1.15 | 2.85 | 7.67 |
Standard deviation | 0.07 | 0.14 | 0.32 | 0.08 | 0.15 | 0.25 |
CV(%) | 6.32 | 5.4 | 3.97 | 6.68 | 5.2 | 3.21 |
RECOVERY
The recovery of Human CD34 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 95-108 | 101 |
EDTA plasma (n=8) | 88-101 | 94 |
Cell culture media (n=8) | 87-100 | 93 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CD34 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TLS ELISA Kits
SRSF10 ELISA Kit | publications with TLS and SRSF10 |
HNRNPK ELISA Kit | publications with TLS and HNRNPK |
YBX1 ELISA Kit | publications with TLS and YBX1 |
SRSF2 ELISA Kit | publications with TLS and SRSF2 |
SRRM1 ELISA Kit | publications with TLS and SRRM1 |
Pathways associated with TLS ELISA Kit
Gene Expression Pathway | Gene Expression Pathway |
Processing Of Capped Intron-Containing Pre-mRNA Pathway | Processing Of Capped Intron-Containing Pre-mRNA Pathway |
Transcriptional Misregulation In Cancer Pathway | Transcriptional Misregulation In Cancer Pathway |
MRNA Splicing Pathway | MRNA Splicing Pathway |
MRNA Splicing - Major Pathway | MRNA Splicing - Major Pathway |
MRNA Processing Pathway | MRNA Processing Pathway |
Diseases associated with TLS ELISA Kit
Nervous System Diseases | publications with TLS and Nervous System Diseases |
Liposarcoma, Myxoid | publications with TLS and Liposarcoma, Myxoid |
Disease Models, Animal | publications with TLS and Disease Models, Animal |
Movement Disorders | publications with TLS and Movement Disorders |
Necrosis | publications with TLS and Necrosis |
Neoplasms, Experimental | publications with TLS and Neoplasms, Experimental |
Adenocarcinoma | publications with TLS and Adenocarcinoma |
Breast Neoplasms | publications with TLS and Breast Neoplasms |
Cell Transformation, Neoplastic | publications with TLS and Cell Transformation, Neoplastic |
Kidney Diseases | publications with TLS and Kidney Diseases |
Organs/Tissues associated with TLS ELISA Kit
Brain | publications with TLS and Brain |
Blood | publications with TLS and Blood |
Nerve | publications with TLS and Nerve |
Muscle | publications with TLS and Muscle |
Bone | publications with TLS and Bone |
Vascular | publications with TLS and Vascular |
Liver | publications with TLS and Liver |
Skin | publications with TLS and Skin |
Kidney | publications with TLS and Kidney |
Eye | publications with TLS and Eye |